241 related articles for article (PubMed ID: 30638766)
1. Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
McCuaig JM; Tone AA; Maganti M; Romagnuolo T; Ricker N; Shuldiner J; Rodin G; Stockley T; Kim RH; Bernardini MQ
Gynecol Oncol; 2019 Apr; 153(1):108-115. PubMed ID: 30638766
[TBL] [Abstract][Full Text] [Related]
2. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
[TBL] [Abstract][Full Text] [Related]
3. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
[TBL] [Abstract][Full Text] [Related]
5. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
[TBL] [Abstract][Full Text] [Related]
6. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
7. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
8. Comparing Outcomes of Genetic Counseling Options in Breast and Ovarian Cancer: An Integrative Review
.
Fournier DM; Bazzell AF; Dains JE
Oncol Nurs Forum; 2018 Jan; 45(1):96-105. PubMed ID: 29251290
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
Brédart A; Kop JL; Dick J; Cano A; De Pauw A; Anota A; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
BMJ Open; 2019 Sep; 9(9):e029926. PubMed ID: 31551380
[TBL] [Abstract][Full Text] [Related]
10. Patient outcomes associated with group and individual genetic counseling formats.
Rothwell E; Kohlmann W; Jasperson K; Gammon A; Wong B; Kinney A
Fam Cancer; 2012 Mar; 11(1):97-106. PubMed ID: 22057473
[TBL] [Abstract][Full Text] [Related]
11. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal.
Audrain J; Schwartz MD; Lerman C; Hughes C; Peshkin BN; Biesecker B
Ann Behav Med; 1997; 19(4):370-7. PubMed ID: 9706364
[TBL] [Abstract][Full Text] [Related]
12. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.
Arver B; Haegermark A; Platten U; Lindblom A; Brandberg Y
Fam Cancer; 2004; 3(2):109-16. PubMed ID: 15340261
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.
Wakefield CE; Meiser B; Homewood J; Peate M; Taylor A; Lobb E; Kirk J; Young MA; Williams R; Dudding T; Tucker K;
Breast Cancer Res Treat; 2008 Jan; 107(2):289-301. PubMed ID: 17333332
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and psychosocial impact of genetic counseling and multigene panel testing among individuals with ovarian cancer.
Pozzar RA; Hong F; Xiong N; Stopfer JE; Nayak MM; Underhill-Blazey M
Fam Cancer; 2022 Jan; 21(1):35-47. PubMed ID: 33751319
[TBL] [Abstract][Full Text] [Related]
16. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
Jacobs AS; Schwartz MD; Valdimarsdottir H; Nusbaum RH; Hooker GW; DeMarco TA; Heinzmann JE; McKinnon W; McCormick SR; Davis C; Forman AD; Lebensohn AP; Dalton E; Tully DM; Graves KD; Similuk M; Kelly S; Peshkin BN
Fam Cancer; 2016 Oct; 15(4):529-39. PubMed ID: 26969308
[TBL] [Abstract][Full Text] [Related]
17. Large-scale group genetic counseling: Evaluation of a novel service delivery model in a Canadian hereditary cancer clinic.
Lohn Z; Fok A; Richardson M; Derocher H; Mung SW; Nuk J; Yuson J; Jevon M; A Schrader K; Sun S
J Genet Couns; 2022 Apr; 31(2):459-469. PubMed ID: 34596310
[TBL] [Abstract][Full Text] [Related]
18. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
[TBL] [Abstract][Full Text] [Related]
19. Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations.
Manchanda R; Burnell M; Loggenberg K; Desai R; Wardle J; Sanderson SC; Gessler S; Side L; Balogun N; Kumar A; Dorkins H; Wallis Y; Chapman C; Tomlinson I; Taylor R; Jacobs C; Legood R; Raikou M; McGuire A; Beller U; Menon U; Jacobs I
J Med Genet; 2016 Jul; 53(7):472-80. PubMed ID: 26993268
[TBL] [Abstract][Full Text] [Related]
20. Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
Kinney AY; Steffen LE; Brumbach BH; Kohlmann W; Du R; Lee JH; Gammon A; Butler K; Buys SS; Stroup AM; Campo RA; Flores KG; Mandelblatt JS; Schwartz MD
J Clin Oncol; 2016 Aug; 34(24):2914-24. PubMed ID: 27325848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
